{
  "id": "NCLEX_NGN_SA_500781771347789690",
  "itemType": "standalone_selectAll",
  "version": "2026",
  "seed": "MISSION-500-78-1771347789690",
  "difficulty": 5,
  "topic": "Management of Care",
  "subtopic": "Hyperosmolar Hyperglycemic State (HHS)",
  "questionText": "The nurse is preparing to administer the 1645 medications and treatments for a client diagnosed with Hyperosmolar Hyperglycemic State (HHS). Based on the client's electronic health record, which actions should the nurse take? Select all that apply.",
  "options": [
    {
      "id": "opt_6",
      "text": "Continue the 0.9% sodium chloride infusion and document intake and output."
    },
    {
      "id": "opt_2",
      "text": "Administer the regular insulin IV infusion as prescribed."
    },
    {
      "id": "opt_1",
      "text": "Withhold the regular insulin IV infusion."
    },
    {
      "id": "opt_5",
      "text": "Request an order for a more aggressive potassium replacement protocol."
    },
    {
      "id": "opt_4",
      "text": "Prepare the client for emergent cardiac catheterization."
    },
    {
      "id": "opt_3",
      "text": "Contact the healthcare provider immediately to discuss the potassium level."
    }
  ],
  "correctAnswer": [
    "opt_1",
    "opt_3",
    "opt_5"
  ],
  "rationale": "In Hyperosmolar Hyperglycemic State (HHS), the primary concern is severe dehydration and hyperglycemia. Insulin is crucial for reducing blood glucose, but administering it with a critically low potassium level (2.4 mEq/L) can be fatal. Insulin shifts potassium intracellularly, further depleting serum potassium and increasing the risk of life-threatening cardiac arrhythmias like ventricular fibrillation or asystole. The ECG changes (flattened T waves, prominent U waves, ST depression) strongly suggest hypokalemia. Therefore, the priority is to withhold insulin, immediately notify the provider about the critical potassium level, and advocate for a more aggressive potassium replacement to stabilize cardiac function before initiating insulin therapy. Failure to address hypokalemia before insulin administration can lead to rapid deterioration and cardiac arrest.",
  "answerBreakdown": [
    {
      "optionId": "opt_1",
      "justification": "Correct. The client's potassium level of 2.4 mEq/L is critically low (normal range: 3.5-5.0 mEq/L). Insulin administration promotes potassium uptake into cells, potentially worsening hypokalemia and leading to cardiac dysrhythmias or arrest. Current guidelines recommend a potassium level above 3.3 mEq/L before initiating insulin therapy. Withholding insulin is crucial for patient safety.",
      "isCorrect": true,
      "scoringWeight": "1"
    },
    {
      "optionId": "opt_2",
      "justification": "Incorrect. Administering insulin with a potassium level of 2.4 mEq/L is dangerous and potentially fatal. It exacerbates hypokalemia, increasing the risk of cardiac arrest. This action demonstrates a failure to recognize a critical contraindication and could result in severe patient harm.",
      "isCorrect": false,
      "scoringWeight": "1"
    },
    {
      "optionId": "opt_3",
      "justification": "Correct. After identifying the critical potassium level and withholding insulin, the nurse must immediately notify the healthcare provider. This communication is essential to report the critical finding, explain the rationale for withholding insulin, and obtain further orders for safe management of the client's condition, including potassium replacement.",
      "isCorrect": true,
      "scoringWeight": "1"
    },
    {
      "optionId": "opt_4",
      "justification": "Incorrect. The ECG findings (ST-segment depression, flattened T waves, prominent U waves) are indicative of hypokalemia, not acute myocardial ischemia. Preparing the client for emergent cardiac catheterization based on these ECG changes would be a misinterpretation of the clinical data and delay appropriate treatment for the electrolyte imbalance.",
      "isCorrect": false,
      "scoringWeight": "1"
    },
    {
      "optionId": "opt_5",
      "justification": "Correct. Given the client's potassium level of 2.4 mEq/L, the current order of 40 mEq of potassium chloride over 4 hours (10 mEq/hr) is likely insufficient. The nurse should advocate for a more aggressive potassium replacement protocol, potentially including a higher infusion rate or a central line for safer administration, to rapidly correct the deficit before initiating insulin therapy. This proactive approach ensures patient safety.",
      "isCorrect": true,
      "scoringWeight": "1"
    },
    {
      "optionId": "opt_6",
      "justification": "Incorrect. While maintaining IV fluids and monitoring intake and output are important in HHS management to address dehydration, they are not the priority in this situation. The immediate priority is addressing the life-threatening hypokalemia and withholding insulin. Focusing solely on fluid management without addressing the electrolyte imbalance could lead to adverse outcomes.",
      "isCorrect": false,
      "scoringWeight": "1"
    }
  ],
  "clientData": {
    "tabs": [
      {
        "id": "nurses_notes",
        "label": "Nurses' Notes",
        "content": [
          {
            "time": "1400",
            "note": "Client, a 48-year-old female, brought to ED by family due to increasing confusion and lethargy over the past 3 days. History of Systemic Lupus Erythematosus (SLE), started on prednisone 60 mg daily two weeks ago for a flare-up. Family reports client has had polydipsia and polyuria. States she missed her last two rheumatology appointments due to lack of transportation from her rural home. Mucous membranes are dry, skin turgor is poor. GCS is 13 (E4, V4, M5). Oriented to person only."
          },
          {
            "time": "1600",
            "note": "Two 18-gauge peripheral IVs established. 0.9% sodium chloride infusion initiated at 1 L/hr per protocol. Awaiting initial lab results. Client remains lethargic but is rousable to verbal stimuli."
          }
        ]
      },
      {
        "id": "vitals",
        "label": "Vital Signs",
        "content": {
          "type": "table",
          "headers": [
            "Time",
            "Temp (Â°C)",
            "HR (bpm)",
            "RR (breaths/min)",
            "BP (mmHg)",
            "SpO2 (%)"
          ],
          "rows": [
            [
              "1415",
              "37.8",
              "128",
              "22",
              "94/56",
              "95"
            ],
            [
              "1515",
              "37.6",
              "116",
              "20",
              "102/64",
              "96"
            ],
            [
              "1615",
              "37.5",
              "110",
              "18",
              "108/70",
              "97"
            ]
          ]
        }
      },
      {
        "id": "labs",
        "label": "Laboratory Results",
        "content": {
          "type": "table",
          "headers": [
            "Test",
            "Result",
            "Reference Range"
          ],
          "rows": [
            [
              "Glucose",
              "980 mg/dL",
              "70-110 mg/dL"
            ],
            [
              "Sodium",
              "148 mEq/L",
              "136-145 mEq/L"
            ],
            [
              "Potassium",
              "2.4 mEq/L",
              "3.5-5.0 mEq/L"
            ],
            [
              "BUN",
              "88 mg/dL",
              "6-20 mg/dL"
            ],
            [
              "Creatinine",
              "2.9 mg/dL",
              "0.6-1.2 mg/dL"
            ],
            [
              "Serum Osmolality, calc.",
              "375 mOsm/kg",
              "275-295 mOsm/kg"
            ],
            [
              "Anion Gap",
              "11 mEq/L",
              "8-12 mEq/L"
            ]
          ],
          "timestamp": "1530"
        }
      },
      {
        "id": "diagnostics",
        "label": "Diagnostic Findings",
        "content": [
          {
            "type": "ECG",
            "timestamp": "1630",
            "interpretation": "Sinus tachycardia at 108 bpm. Flattened T waves, prominent U waves, and ST-segment depression are noted."
          }
        ]
      },
      {
        "id": "mar",
        "label": "MAR",
        "content": {
          "type": "table",
          "headers": [
            "Time Due",
            "Medication/Treatment",
            "Dose/Rate",
            "Status"
          ],
          "rows": [
            [
              "1645",
              "0.9% Sodium Chloride",
              "Continue at 500 mL/hr",
              "Infusing"
            ],
            [
              "1645",
              "Regular Insulin IV Infusion",
              "0.1 units/kg/hr",
              "Pending"
            ],
            [
              "1645",
              "Potassium Chloride IV",
              "40 mEq in 100 mL 0.9% NaCl over 4 hours",
              "Pending"
            ],
            [
              "1645",
              "Ceftriaxone",
              "1g IV",
              "Pending"
            ]
          ]
        }
      }
    ]
  },
  "clinicalPearls": "Always assess potassium levels before initiating insulin therapy, especially in patients with HHS. Severe hypokalemia can lead to life-threatening cardiac dysrhythmias. ECG changes such as flattened T waves, prominent U waves, and ST-segment depression are indicative of hypokalemia. Prioritize potassium replacement before or concurrently with insulin administration.",
  "sbar": {
    "situation": "1645: The client is a 48-year-old female with Hyperosmolar Hyperglycemic State (HHS) and a critically low potassium level of 2.4 mEq/L.",
    "background": "The client has a history of Systemic Lupus Erythematosus (SLE) and was recently started on prednisone 60mg daily. She presents with confusion, lethargy, polydipsia, and polyuria. Initial labs reveal a glucose of 980 mg/dL, sodium of 148 mEq/L, potassium of 2.4 mEq/L, BUN of 88 mg/dL, creatinine of 2.9 mg/dL and serum osmolality of 375 mOsm/kg. ECG shows sinus tachycardia, flattened T waves, prominent U waves, and ST-segment depression.",
    "assessment": "The client's severe hypokalemia (2.4 mEq/L) poses a significant risk for cardiac dysrhythmias and cardiac arrest. The current orders include a regular insulin infusion at 0.1 units/kg/hr, which is contraindicated due to the hypokalemia. The client is also receiving 0.9% Sodium Chloride at 500mL/hr and has an order for Potassium Chloride 40 mEq in 100 mL 0.9% NaCl over 4 hours.",
    "recommendation": "Withhold the regular insulin IV infusion due at 1645. Immediately contact the healthcare provider to report the critical potassium level and request a more aggressive potassium replacement protocol, potentially via central line, before initiating insulin therapy. Continue to monitor vital signs and ECG for changes."
  },
  "sentinelStatus": "healed_v2026_v8"
}